The use of gene-modified tumor-infiltrating lymphocytes for cancer therapy.
Surgery Branch, National Cancer Institute, Bethesda, Maryland 20892.
P
P
Hwu
S A
SA
Rosenberg
D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*; D011971:Receptors, Immunologic / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000235:genetics; D012190:Retroviridae / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D011971:Receptors, Immunologic; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha